Selective inhibition of MBNL1–CCUG interaction by small molecules toward potential therapeutic agents for myotonic dystrophy type 2 (DM2)(†)

Myotonic dystrophy type 2 (DM2) is an incurable neuromuscular disease caused by expanded CCUG repeats that may exhibit toxicity by sequestering the splicing regulator MBNL1. A series of triaminotriazine- and triaminopyrimidine-based small molecules (ligands 1–3) were designed, synthesized and tested...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Chun-Ho, Fu, Yuan, Ramisetty, Sreenivasa Rao, Baranger, Anne M., Zimmerman, Steven C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
RNA
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203617/
https://www.ncbi.nlm.nih.gov/pubmed/21768123
http://dx.doi.org/10.1093/nar/gkr415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203617/
https://www.ncbi.nlm.nih.gov/pubmed/21768123
http://dx.doi.org/10.1093/nar/gkr415

Ejemplares similares